41. Chang FY, Siu LK, Fung CP, Huang MH, Ho M. Diversity of SHV and TEMb-lactamases in Klebsiella pneumoniae: gene evolution in northern Taiwan and two novel beta-lactamases, SHV-25 and SHV-26. Antimicrob Agents Chemother 2001;45:2407-13. 42. Yan JJ, Ko WC, Wu JJ. Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:2368-71. 43. Yan JJ, Ko WC, Tsai SH, Wu HM, Lin YT, Wu JJ. Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escher- ichia coli in southern Taiwan. J Clin Microbiol 2000;38:4320-5. 44. Wang JH, Liu YC, Lee SSJ, Yen MY, Chen YS, Wang JH, et al. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 1998;26:1434-8. 45. Fung CP, Hu BS, Chang FY, Lee SC, Kuo BI, Ho M, et al. A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy. J Infect Dis 2000;181:2075-9. 46. Hsueh PR, Teng LJ, Chen YC, Luh KT. Primary liver abscess caused by one clone of Klebsiella pneumoniae with two colonial morphotypes and resistotypes. Emerg Infect Dis 2002;8:100-5. 47. Su LH, Chiu CH, Kuo AJ, Chia JH, Sun CF, Leu HS, et al. Secular trends in incidence and antimicrobial resistance among clinical isolates of Sal- monella at a university hospital in Taiwan, 1993-1999. Epidemiol Infect. 2001;127:207-13. SYNOPSIS 48. Liu PYF, Lau YJ, Hu BS, Shyr JM, Shi ZY, Tsai WS, et al. Comparison of susceptibility to extended-spectrum beta-lactam antibiotics and ciproflox- acin among gram-negative bacilli isolated from intensive care units. Diagn Microbiol Infect Dis 1995;22:285-91. 49. Chen ML, Hsueh PR, Lee LN, Yu CJ, Yang PC, Luh KT. Severe commu- nity-acquired pneumonia due to Acinetobacter baumannii. Chest 2001; 120: 1072-7. 50. Yan JJ, Hsueh PR, Ko WC, Luh KT, Tsai SH, Wu HM, et al. Metallo- beta-lactamases among clinical isolates of Pseudomonas in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimi- crob Agents Chemother 2001;45:2224-8. 51. Ko WC, Yu KW, Liu CY, Huang CT, Leu HS, Chuang YC. Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan. Antimicrob Agents Chemother 1996;40:1260-2. 52. Ko WC, Wu HM, Chang TC, Yan JJ, Wu JJ. Inducible beta-lactam resis- tance in Aeromonas hydrophila: therapeutic challenge for antimicrobial therapy. J Clin Microbiol 1998;36:3188-92. 53. Li CC, Chiu CH, Wu JL, Huang YC, Lin TY. Antimicrobial susceptibility of Campylobacter jejuni and coli by using E-Test in Taiwan. Scand J Infect Dis 1998;30:39-42. 54. McDonald LC, Chen MT, Lauderdale TL, Ho M. The use of antibiotics critical to human medicine in food-producing animals in Taiwan. J Micro- biol Immunol Infect 2001;34:97-102. Address for correspondence: Kwen-Tay Luh, Department of Laboratory Med- icine, National Taiwan University Hospital, No. 7 Chung-Shan Road, Taipei 100, Taiwan; fax: 886-2-2322-4263; e-mail: luhkt@ha.mc.ntu.edu.tw The print journal is available at no charge to public health professionals YES, I would like to receive Emerging Infectious Diseases. Please print your name and business address in the box and return by fax to 404-371-5449 or mail to EID Editor CDC/NCID/MS D61 1600 Clifton Road, NE Atlanta, GA 30333 Moving? Please give us your new address (in the box) and print the number of your old mailing label here______________ Emerging Infectious Diseases • Vol. 8, No. 2, February 2002 137